BRIEF published on 09/08/2026 at 08:50, 1 month 26 days ago Innoscripta Expands in Austrian Market, Exceeds EUR 1 Million Order Backlog International Growth Austrian Market R&D Tax Credit Clusterix Platform Innoscripta Expansion
PRESS RELEASE published on 09/08/2026 at 08:45, 1 month 26 days ago innoscripta expands business in established Austrian market – order backlog exceeds EUR 1 million innoscripta SE expands business in the Austrian market with order backlog exceeding EUR 1 million. Sales team successfully established in Vienna, attracting 30+ customers Order Backlog Austrian Market Vienna R&D Tax Credit Innoscripta SE
BRIEF published on 08/25/2026 at 08:35, 2 months 10 days ago Innoscripta SE Reports Strong Growth in First Half of 2026 Revenue Growth International Expansion Innoscripta SE Clusterix Platform 2026 Financial Guidance
PRESS RELEASE published on 08/25/2026 at 08:30, 2 months 10 days ago innoscripta SE: Successful First Half of 2026 innoscripta SE reports successful first half of 2026 with revenue up 43% and adjusted EBIT increasing by 49%. International expansion on track with market entries in France, UK, and US Revenue Growth International Expansion EBIT Increase Innoscripta SE Clusterix
BRIEF published on 08/12/2026 at 08:52, 2 months 23 days ago Innoscripta SE Enters US Market Addressing New IRS R&D Documentation Needs International Expansion US Market Entry IRS Requirements R&D Documentation Clusterix Software
PRESS RELEASE published on 08/12/2026 at 08:47, 2 months 23 days ago innoscripta SE: Successful US Market Entry – Clusterix Addresses New IRS Documentation Requirements under Form 6765 innoscripta SE secures US market entry with new IRS documentation requirements addressed under Form 6765, attracting international customers in the largest R&D market US Market Entry Innoscripta SE IRS Documentation Form 6765 R&D Market
BRIEF published on 07/29/2026 at 08:48, 3 months 6 days ago Innoscripta SE Expands into the UK Market UK Market R&D Tax Incentives Clusterix Platform Innoscripta Expansion Software Customer
PRESS RELEASE published on 07/29/2026 at 08:43, 3 months 6 days ago innoscripta SE Launches Expansion into the United Kingdom innoscripta SE expands into the United Kingdom, acquiring its first UK software customer for R&D tax relief claims with Clusterix platform adapted to UK regulations Innoscripta SE Clusterix Platform UK Market Entry United Kingdom Expansion R&D Tax Relief
BRIEF published on 07/08/2026 at 08:43, 3 months 27 days ago Innoscripta SE Expands with New Hamburg Office Regional Expansion Clusterix Platform R&D Efficiency Innoscripta Hamburg Office
PRESS RELEASE published on 07/08/2026 at 08:38, 3 months 27 days ago innoscripta SE Accelerates Regional Expansion with New Hamburg Office innoscripta SE accelerates regional expansion by opening new Hamburg office, strengthening German market presence and team for Clusterix platform rollout German Market Regional Expansion Innoscripta SE Clusterix Platform Hamburg Office
Published on 11/04/2026 at 15:55, 2 hours 6 minutes ago Boba Mint Outlines Planned Heatcheck Rebrand and Asset Restructuring and Announces Cease Trade Order
Published on 11/04/2026 at 15:07, 2 hours 54 minutes ago Boron One Signs Second Binding Offtake Agreement for Sale of Boron Concentrates and Refined Boron Products
Published on 11/04/2026 at 15:00, 3 hours 1 minute ago Vox Royalty Provides Update & Timeline for Assets Entering Production
Published on 11/04/2026 at 15:00, 3 hours 1 minute ago ShelfieTech Announces Closing of Acquisition of Majority Interest in Aspect
Published on 11/04/2026 at 14:00, 4 hours 1 minute ago Adcore to Publish Third Quarter 2026 Results on November 10, 2026
Published on 11/04/2026 at 17:30, 30 minutes ago Kudelski Security Joins CrowdStrike Project QuiltWorks to Accelerate Remediation Against Frontier AI Risk
Published on 11/04/2026 at 17:30, 30 minutes ago Artprice by Artmarket presents a liber mundi, dixit Gemini: 'Dialogue Between a Thinker and AI' carries within it the serene, yet profound, echo of the greatest anthropological shock of our era
Published on 11/04/2026 at 16:36, 1 hour 24 minutes ago Heidelberg Pharma to Present New Clinical Data on its ATAC Candidates at the ASH Annual Meeting 2026
Published on 11/04/2026 at 16:30, 1 hour 30 minutes ago "Taiwan Weeks 2026" Opens as Taiwan Strengthens Global Capital Market Connectivity
Published on 11/04/2026 at 16:20, 1 hour 40 minutes ago Viromed Medical AG Receives Approval for ViroCAP® med in Turkey and Announces Further Operational Progress
Published on 11/04/2026 at 17:44, 17 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Published on 11/04/2026 at 11:56, 6 hours 4 minutes ago Mersen: Number of shares and voting rights as of October 31, 2026
Published on 11/03/2026 at 18:00, 1 day ago Outstanding Shares and Voting Rights Monthly Statement - 31 October 2026
